The leiomyosarcoma treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.30% in the above-mentioned research forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of the leiomyosarcoma treatment market. Some of the drugs for the treatment of leiomyosarcoma (LMS) are under clinical trials.
For instance,
-
Avelumab is under phase I clinical trial which is an immunotherapy with monoclonal antibodies which will be used for the treatment of LMS and stop the overgrowth of cancer cells.
-
Temozolomide and cabozantinib are also under phase II clinical trials which are used for the patients with LMS. These drugs will either stop the growth of cancer cells or prevent them from spreading.
Leiomyosarcoma (LMS) is a type of soft tissue sarcoma that mainly affects the smooth muscle tissue. This type of tumor can affect any part of the body such as bladder, stomach, intestine, blood vessels, liver and many others but mainly affect the abdomen including the uterus. The main cause for the cancer is not still detected but it can occur due to the genetic changes which lead to overgrowth of cancer cells. Risk factors for LMS can be the exposure of pesticides, weed killers or vinyl chloride. LMS in the stomach can cause various symptoms such as stomach pain, blood during vomiting and passing of black colored stools whereas LMS in the uterus leads to unnecessary vaginal bleeding and frequent urination.
The increased prevalence of soft tissue sarcomas is one of the driving factors for the leiomyosarcoma treatment market. For instance, in the United States, total new cases diagnosed for soft tissue sarcomas are 13,460 and 5,350 people are expected to die from this type of cancer. LMS mainly occurs in the abdominal region which also includes the uterus. 50% of leiomyosarcoma occurs in the retroperitoneum site. Increase in the women population having fibroids may have the chances to develop LMS . one out of five of every 1,000 women are suffering from this cancer which acts as a driver for the leiomyosarcoma treatment market growth. Side-effects related to the chemotherapy and radiotherapy of the LMS may hamper the leiomyosarcoma treatment market growth. For instance, skin problems, fatigue, stomach discomfort, sexual problems especially for the male population, dry mouth, anemia, hair loss and many other side-effects.
Get Full Access of Report @
https://www.databridgemarketresearch.com/reports/global-leiomyosarcoma-treatment-market
Patient Epidemiology Analysis
The leiomyosarcoma treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to leiomyosarcoma treatment market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the leiomyosarcoma treatment market in the growth period.
Competitive Landscape and Leiomyosarcoma Treatment Market Share Analysis
The leiomyosarcoma treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the global leiomyosarcoma treatment market.
The major players covered in the global leiomyosarcoma treatment market report are Bristol-Myers Squibb Company, Novartis AG, Merck & Co., Inc., Genentech Inc., F. Hoffmann-La Roche AG, Amgen Inc., AstraZeneca, Daiichi Sankyo Company Limited, AB Sciences, AgonOX, Inc., Eisai Co., Ltd., GlaxoSmithKline, plc, Pfizer, Inc., and Vical, Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @
Leiomyosarcoma Treatment Market Scope and Market Size
The leiomyosarcoma treatment market is segmented on the basis of grade, classification, diagnosis, treatment, end-user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
-
On the basis of grade, the leiomyosarcoma treatment market is segmented into low grade, high grade and other.
-
On the basis of classification, the leiomyosarcoma treatment market is segmented into leiomyosarcoma of soft tissue, leiomyosarcoma of cutaneous origin, leiomyosarcoma of vascular origin, leiomyosarcoma in the immunocompromised host and leiomyosarcoma of bone.
-
On the basis of diagnosis, the leiomyosarcoma treatment market is segmented into blood test, ultrasound, computed tomography (CT) scan and magnetic resonance imaging (MRI) scan.
-
On the basis of treatment, the leiomyosarcoma treatment market is segmented into surgery, radiotherapy and chemotherapy. Chemotherapy is further segmented to doxorubicin and ifosfamide, gemcitabine and taxotere (docetaxel), dacarbazine and ecteinascidin.
-
On the basis of end user, the leiomyosarcoma treatment market is segmented to cancer research institutes, diagnostic laboratories, hospitals and others.
-
On the basis of distribution channel, the leiomyosarcoma treatment market is segmented into hospital pharmacy, retail pharmacy and others.
Global Leiomyosarcoma Treatment Market Country Level Analysis
Global leiomyosarcoma treatment market is analysed and market size information is provided by country, grade, classification, diagnosis, treatment, end-user and distribution channel as referenced above.
The countries covered in the leiomyosarcoma treatment market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts the largest market share due to the presence of high healthcare expenditure and favourable reimbursement policies for the treatment. Europe accounts for the second largest market share due to increased genetic disorders and presence of refined medical facilities. Asia-Pacific is expected to account for the largest market share over coming years for the leiomyosarcoma treatment market due to constant rise in the incidence of cancer coupled with increased demand for cost-efficient therapeutics.
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC @
https://www.databridgemarketresearch.com/toc/?dbmr=global-leiomyosarcoma-treatment-market
Top Trending Reports by DBMR:
Global Chronic Disease Management Market
https://www.databridgemarketresearch.com/reports/global-chronic-disease-management-market
Global Cannabis Seeds Market
https://www.databridgemarketresearch.com/reports/global-cannabis-seeds-market
Global Natural Killer (NK) Cell Therapeutics market
https://www.databridgemarketresearch.com/reports/global-natural-killer-nk-cell-therapeutics-market
U.S. Diet and Nutrition Apps market
https://www.databridgemarketresearch.com/reports/us-diet-and-nutrition-apps-market
Global Denim market
https://www.databridgemarketresearch.com/reports/global-denim-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek